Flake A W, Harrison M R
Department of Surgery, University of California, San Francisco 94143, USA.
Annu Rev Med. 1995;46:67-78. doi: 10.1146/annurev.med.46.1.67.
Fetal surgery, as defined for the purpose of this chapter, is the act of opening the gravid uterus, surgically correcting a fetal abnormality, and returning the fetus to the uterus for postoperative recovery and continued gestational development. By this definition, human fetal surgery has now been performed for more than a decade, primarily at a single center (1). Tremendous progress has been made in our understanding of the natural history and pathophysiology of fetal disease, in solving the technical challenges of fetal surgery, and in intra- and postoperative care and monitoring of the maternal-fetal unit. However, success and general application of fetal surgery continue to be limited by a number of unsolved and formidable problems. The most important of these is the control of preterm labor, which is the Achilles heel of fetal surgery. Preterm labor is to the infantile field of fetal surgery what rejection was to the field of transplantation. The discovery of effective tocolysis would be analogous to the development of effective immunosuppression and would allow fetal surgery to achieve its full potential. In addition, less invasive methods of operating on the fetus are emerging that will further reduce the maternal and fetal risk of this currently highly invasive treatment.
本章所定义的胎儿手术是指打开妊娠子宫,通过手术矫正胎儿异常,然后将胎儿送回子宫进行术后恢复及继续妊娠发育的行为。按照这个定义,人类胎儿手术目前已经开展了十多年,主要集中在单一中心(1)。在我们对胎儿疾病的自然病史和病理生理学的理解、解决胎儿手术的技术难题以及对母胎单元的术中及术后护理和监测方面,都取得了巨大进展。然而,胎儿手术的成功及广泛应用仍然受到一些尚未解决的重大问题的限制。其中最重要的是早产的控制,这是胎儿手术的致命弱点。早产之于胎儿手术领域,就如同排斥反应之于移植领域。有效宫缩抑制剂的发现将类似于有效免疫抑制剂的研发,并将使胎儿手术充分发挥其潜力。此外,正在出现的对胎儿进行手术的侵入性较小的方法,将进一步降低这种目前具有高度侵入性的治疗对母体和胎儿的风险。